Tech Company Financing Transactions

Anthera Pharmaceuticals Funding Round

On 1/12/2018, Anthera Pharmaceuticals secured $12.1 million in funding from private investors.

Transaction Overview

Announced On
1/12/2018
Transaction Type
Venture Equity
Amount
$12,116,579
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 21 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
700 Milam 1300
Houston, TX 77002
USA
Phone
Undisclosed
Email Address
Overview
Anthera Pharmaceuticals is focused on developing products to treat diseases associated with inflammation and autoimmune diseases.
Profile
Anthera Pharmaceuticals LinkedIn Company Profile
Social Media
Anthera Pharmaceuticals Company Twitter Account
Company News
Anthera Pharmaceuticals News
Facebook
Anthera Pharmaceuticals on Facebook
YouTube
Anthera Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chairman
Paul Truex
  Paul Truex LinkedIn Profile  Paul Truex Twitter Account  Paul Truex News  Paul Truex on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/12/2018: Braeburn Pharmaceuticals venture capital transaction
Next: 1/12/2018: HelloTeam venture capital transaction

 

Share this article

 


Where The Data Comes From

We report on tech company VC transactions. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary